Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1997 Nov;50(11):919–922. doi: 10.1136/jcp.50.11.919

Normal distribution of collagen IV in renal basement membranes in Epstein's syndrome.

I Naito 1, S Nomura 1, S Inoue 1, M Kagawa 1, S Kawai 1, Y Gunshin 1, K Joh 1, C Tsukidate 1, Y Sado 1, G Osawa 1
PMCID: PMC500315  PMID: 9462240

Abstract

BACKGROUND: Epstein's syndrome is defined as a subtype of Alport's syndrome, and is distinguished from the other subtypes by accompanying macrothrombocytopenia. Mutations in collagen IV genes are known to be involved in the pathogenesis of typical Alport's syndrome. However, the presence of an underlying genetic defect has not been demonstrated in Epstein's syndrome. AIM: To clarify the involvement of collagen IV in Epstein's syndrome. METHODS: The distribution of the alpha(IV) chain was studied in renal specimens obtained from three patients with Epstein's syndrome using chain specific monoclonal antibodies and an antigen retrieval procedure. RESULTS: The patients showed a normal distribution of alpha(IV) chains: alpha 1(IV) and alpha 2(IV) were expressed ubiquitously, whereas expression of alpha 3(IV) through to alpha 6(IV) chains was limited to the glomerular basement membrane, Bowman's capsular basement membrane, and/or a portion of the tubular basement membrane. CONCLUSIONS: These results suggest that genes other than those encoding alpha(IV) chains are responsible for the pathogenesis of Epstein's syndrome.

Full text

PDF
922

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barker D. F., Hostikka S. L., Zhou J., Chow L. T., Oliphant A. R., Gerken S. C., Gregory M. C., Skolnick M. H., Atkin C. L., Tryggvason K. Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Science. 1990 Jun 8;248(4960):1224–1227. doi: 10.1126/science.2349482. [DOI] [PubMed] [Google Scholar]
  2. Epstein C. J., Sahud M. A., Piel C. F., Goodman J. R., Bernfield M. R., Kushner J. H., Ablin A. R. Hereditary macrothrombocytopathia, nephritis and deafness. Am J Med. 1972 Mar;52(3):299–310. doi: 10.1016/0002-9343(72)90017-4. [DOI] [PubMed] [Google Scholar]
  3. Kashtan C., Fish A. J., Kleppel M., Yoshioka K., Michael A. F. Nephritogenic antigen determinants in epidermal and renal basement membranes of kindreds with Alport-type familial nephritis. J Clin Invest. 1986 Oct;78(4):1035–1044. doi: 10.1172/JCI112658. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Kawai S., Nomura S., Harano T., Harano K., Fukushima T., Osawa G. The COL4A5 gene in Japanese Alport syndrome patients: spectrum of mutations of all exons. The Japanese Alport Network. Kidney Int. 1996 Mar;49(3):814–822. doi: 10.1038/ki.1996.113. [DOI] [PubMed] [Google Scholar]
  5. Lemmink H. H., Mochizuki T., van den Heuvel L. P., Schröder C. H., Barrientos A., Monnens L. A., van Oost B. A., Brunner H. G., Reeders S. T., Smeets H. J. Mutations in the type IV collagen alpha 3 (COL4A3) gene in autosomal recessive Alport syndrome. Hum Mol Genet. 1994 Aug;3(8):1269–1273. doi: 10.1093/hmg/3.8.1269. [DOI] [PubMed] [Google Scholar]
  6. Mochizuki T., Lemmink H. H., Mariyama M., Antignac C., Gubler M. C., Pirson Y., Verellen-Dumoulin C., Chan B., Schröder C. H., Smeets H. J. Identification of mutations in the alpha 3(IV) and alpha 4(IV) collagen genes in autosomal recessive Alport syndrome. Nat Genet. 1994 Sep;8(1):77–81. doi: 10.1038/ng0994-77. [DOI] [PubMed] [Google Scholar]
  7. Naito I., Kawai S., Nomura S., Sado Y., Osawa G. Relationship between COL4A5 gene mutation and distribution of type IV collagen in male X-linked Alport syndrome. Japanese Alport Network. Kidney Int. 1996 Jul;50(1):304–311. doi: 10.1038/ki.1996.316. [DOI] [PubMed] [Google Scholar]
  8. Nakanishi K., Yoshikawa N., Iijima K., Kitagawa K., Nakamura H., Ito H., Yoshioka K., Kagawa M., Sado Y. Immunohistochemical study of alpha 1-5 chains of type IV collagen in hereditary nephritis. Kidney Int. 1994 Nov;46(5):1413–1421. doi: 10.1038/ki.1994.413. [DOI] [PubMed] [Google Scholar]
  9. Pihlajaniemi T. Molecular properties of the glomerular basement membrane. Contrib Nephrol. 1996;117:46–79. doi: 10.1159/000424807. [DOI] [PubMed] [Google Scholar]
  10. Renieri A., Bruttini M., Galli L., Zanelli P., Neri T., Rossetti S., Turco A., Heiskari N., Zhou J., Gusmano R. X-linked Alport syndrome: an SSCP-based mutation survey over all 51 exons of the COL4A5 gene. Am J Hum Genet. 1996 Jun;58(6):1192–1204. [PMC free article] [PubMed] [Google Scholar]
  11. Sado Y., Kagawa M., Kishiro Y., Sugihara K., Naito I., Seyer J. M., Sugimoto M., Oohashi T., Ninomiya Y. Establishment by the rat lymph node method of epitope-defined monoclonal antibodies recognizing the six different alpha chains of human type IV collagen. Histochem Cell Biol. 1995 Oct;104(4):267–275. doi: 10.1007/BF01464322. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES